PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\', \'German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.\', \'Helmholtz Innovation Lab BaoBab (Brain Antibody-omics and B-cell Lab), Berlin, Germany.\', \'Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.\', \'Neuroscience Research Center (NWFZ), Cluster NeuroCure, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\', \'Institute of Virology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\', \'German Centre for Infection Research (DZIF), Berlin, Germany.\', \'Labor Berlin-Charité Vivantes GmbH, Berlin.\', \'Flow and Mass Cytometry Core Facility, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.\', \'Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Germany.\', \'German Center for Infection Research (DZIF), partner site Munich, Germany.\', \'Department of Internal Medicine, BKH Schwaz, Schwaz, Austria.\', \'Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.\', \'The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.\', \'Department of Pediatric Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/science.abm5835
?:doi
?:hasPublicationType
?:journal
  • Science (New York, N.Y.)
is ?:pmid of
?:pmid
?:pmid
  • 35076281
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all